Talk:Emergent BioSolutions

message: In the AfD linked above, the following news sources were found   . If someone could make these references, that'd be great. Cheers, Daniel.Bryant [ T · C ] 06:27, 1 November 2006 (UTC)
thread_title:  Untitled 

message: :Image:Emergent logo s1 rgb.jpg is being used on this article. I notice the image page specifies that the image is being used under fair use but there is no explanation or rationale as to why its use in Wikipedia articles constitutes fair use. In addition to the boilerplate fair use template, you must also write out on the image description page a specific explanation or rationale for why using this image in each article is consistent with fair use.
Please go to the image description page and edit it to include a fair use rationale. Using one of the templates at Wikipedia:Fair use rationale guideline is an easy way to insure that your image is in compliance with Wikipedia policy, but remember that you must complete the template. Do not simply insert a blank template on an image page.
If there is other other fair use media, consider checking that you have specified the fair use rationale on the other images used on this page.  Note that any fair use images uploaded after 4 May, 2006, and lacking such an explanation will be deleted one week after they have been uploaded, as described on criteria for speedy deletion. If you have any questions please ask them at the Media copyright questions page. Thank you.BetacommandBot 04:41, 3 June 2007 (UTC)
thread_title: Fair use rationale for Image:Emergent logo s1 rgb.jpg

message: To whom it may concern: I am writing here on behalf of Emergent BioSolutions (EBS), the subject of this article. They would like to see it better organized and updated, and have asked me to represent them. In so doing, I have researched and written a proposed replacement draft, which is available here: User:Stellatarum/Emergent_BioSolutions
 
The problem with the current version should be apparent. Chiefly, the article is almost entirely unsupported by citations and the few references used now are not true third-party citations. Furthermore, the article is not very well organized. For example, the entire body of the article is listed under "History", and includes some details that aren't really germane to an encyclopedia entry about the company. 
 
My draft aims to address these issues, and give a more accurate picture of the company. The new draft contains 26 citations, from general press and industry journal sources, is more logically organized, and is roughly the same length. I'll note here that if you see a turn of phrase that sounds odd, it's likely because EBS is mindful of FDA regulations regarding their view of what constitutes promotional product information and we want to follow those. For example, in order to make certain statements I would be obliged to include FDA-required "small print" which I'm well aware Wikipedia does not wish to include. I hope this isn't a problem; if another editor makes changes later on with Wikipedia guidelines in mind, I won't object. I just can't be the one to do that.
 
So I invite all constructive comments, and if you agree this draft is better than the current one, please feel free to move it over, or give me the OK to do so. Thank you. --Stellatarum (talk) 18:41, 13 October 2011 (UTC)
replies: text: Nice article, it is definitely an improvement. I'll copy it over if you would like. Alpha_Quadrant  (talk) 03:00, 14 October 2011 (UTC)
replies: text: Thanks, Alpha Quadrant! I appreciate you taking the time to review and copy it over. --Stellatarum (talk) 14:44, 14 October 2011 (UTC)
thread_title:  EBS article 

message: Hello, I would like to ask on behalf of the company that the article be updated to reflect the announcement that Fuad El-Hibri has retired as the head of the company. While the transition has been planned since December, it becomes official this weekend, and has already been the subject of third-party news coverage.
There are two specific updates that are needed: 
*The infobox needs to state that Daniel J. Abdun-Nabi is now the CEO & president.
*The "Overview" section should note El-Hibri's retirement as CEO and his continuing role as executive chairman of Emergent BioSolutions' board of directors.
Both changes can be cited to The Washington Post's Capital Business Blog, Washington Business Journal and Gazette.Net.
The wording I would propose for the "Overview" section is:
:Fuad El-Hibri, the former CEO of Emergent BioSolutions led the company since its founding as BioPort Inc. until his retirement on April 1, 2012. He continues to serve as the executive chairman of Emergent BioSolutions’ board of directors.
If you agree to these changes, please can you update the article. Thank you.
--Stellatarum (talk) 14:22, 30 March 2012 (UTC)
replies: text: --ukexpat (talk) 19:11, 3 April 2012 (UTC)
replies: text: Thanks, Ukexpat! Your assistance with these updates is appreciated. --Stellatarum (talk) 19:29, 3 April 2012 (UTC)
thread_title:  El-Hibri retirement 

message: Hello, on behalf of Emergent BioSolutions, I would like to ask for an update to this article to reflect the company's partnership with the U.S. Department of Health and Human Services. I have written a proposed draft for a new subsection, to add under "History":
:===Government partnership===
:In June 2012, Emergent, along with Novartis and the Texas A&M University System, was selected by the U.S. Department of Health and Human Services as one of the three Centers for Innovation in Advanced Development and Manufacturing. The public-private partnership granted Emergent $163 million over eight years to assist in the development of countermeasures for health, nuclear and radiological epidemics.  
If this draft looks to be ok, please can you move it into the article. Thank you. --Stellatarum (talk) 22:14, 1 February 2013 (UTC)
replies: text: --ukexpat (talk) 13:47, 4 February 2013 (UTC)
thread_title:  New government partnership 

message: The lead section is a bit outdated, and doesn't reflect Emergent's current activities, particularly regarding its government partnerships. I would suggest changing this portion:
:multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. Emergent develops vaccines and therapeutics targeting infectious diseases, oncology and autoimmune disorders
It would be more accurate as follows:
:multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. Emergent offers vaccines, therapeutics and specialized products to healthcare providers and governments to address medical needs and emerging health threats.
Specialty pharmaceutical company is not a marketing term but an industry sector, as this Research and Markets report shows, and the term is applied to other firms on Wikipedia. The phrase is similar to how Emergent describes itself in press releases, though the wording is necessarily specific, and non-promotional. I am open to alternative wording or quotation marks if others deem it necessary. Stellatarum (talk) 23:33, 8 February 2013 (UTC)
replies: text: Hello CorporateM, I certainly can. While not a long article, this AP report carried by Businessweek states that EBS "provides specialty pharmaceutical products such as the anthrax vaccine." This language is different from how EBS uses the term but is still accurate. Does this help? Stellatarum (talk) 15:52, 14 February 2013 (UTC)
replies: text: Ok, giving this a closer lookover. develops - > offers is not an improvement and I see no reason to add "specialized products" when it already says "specialty biopharma..." Adding information about the target market, such as "healthcare providers and government" could be encyclopedic, if it differs somehow from the obvious and the secondary source offers some detailed analysis, but we wouldn't add it to the lead. "to address medical needs" is benefits-oriented language, which is always promotional. I believe the current text is better on all counts and this is not an improvement. I don't think this is a matter of being "outdated" or more "accurate" as is positioned in the request, but when the two versions are compared, it is mostly related to adding positioning aligned with corporate messaging. If something is factually incorrect or outdated, I would encourage you to point out the actual error. CorporateM (Talk) 17:09, 16 February 2013 (UTC)
replies: text: CorporateM, I am unhappy that you have deemed my request "misleading" when I am trying to operate in good faith with Wikipedia rules, and frustrated that you mark my request as fulfilled after each reply, closing off discussion so quickly. I must also disagree with several assertions you have made, but one stands out: you say I see no reason to add "specialized products" when it already says "specialty biopharma...". This article does not presently refer to EBS as a "specialty biopharmaceutical company". This in fact is one of my requested changes, and I have provided a third-party source (Associated Press republished by Bloomberg Businessweek) to verify it. Within the medical industry it is very important to carefully describe what a business does and does not do (the FDA rules are very strict) and that is what my request intends to address, since EBS has recently changed its focus. This is not about corporate messaging but ensuring that this article does not mislead as to EBS's current business model. If you are able to make this change, please do and we may consider the other changes. If you do not have time to help, I will try to find an editor with more time and attention. Stellatarum (talk) 17:32, 18 February 2013 (UTC)
thread_title:  Lead section 

message: I looked at this article. It doesn't really read like a news release. It doesn't seem to violate anything listed here (which would be the requirements for the article to read like a news release): https://en.wikipedia.org/wiki/Wikipedia:NOT#NEWS.
User:DGG can you please offer supporting evidence for your tag? Otherwise, we need to remove that tag. Thanks. Trendyrandy7290 (talk) 15:27, 18 March 2014 (UTC)
thread_title:  news release tag 

message: * Someone applied the news release tag. Which was true. 
* Overhauled page. 
* Goal was to make the text neutral, provide a more robust picture of the company including its acquisition history,
* place its products in a table similar to other company articles, etc. Also broaden the number of sources and types
* of sources.
Thanks Nhj78992 (talk) 23:50, 24 May 2014 (UTC)
thread_title:  removed "reads like news release tag," overhauled page 

message: * Fixed spelling of BioThrax (the T is capitalized)
* Deleted assets and equity from infobox because they are outdated
* Deleted market capitalization from infobox because it is a financial figure that changes everyday with a company's stock price. Therefore, almost impossible to keep it current and factual.
* The company changed its headquarters location. Updated in lead section.
* Deleted the "Historic Background section." Wikipedia already has extensive coverage of the 9/11 anthrax attacks. Seems off-topic to this page.
* Added two rows to the products table
Heart2heartjennifer (talk) 18:31, 13 May 2015 (UTC)
thread_title:  Multiple edits 13 May 2015 

message: Hello fellow Wikipedians,
I have just modified 2 external links on Emergent BioSolutions. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
*Added archive https://web.archive.org/web/20130801072803/http://www.gazette.net/article/20120330/NEWS/703309706/1033/emergent-s-fuad-el-hibri-an-entrepreneur-at-heart%26template%3Dgazette to http://www.gazette.net/article/20120330/NEWS/703309706/1033/emergent-s-fuad-el-hibri-an-entrepreneur-at-heart%26template%3Dgazette
*Added archive https://archive.is/20130813181714/http://ca.finance.yahoo.com/news/emergent-biosolutions-receives-paul-ehrlich-110000071.html to http://ca.finance.yahoo.com/news/emergent-biosolutions-receives-paul-ehrlich-110000071.html
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
Cheers.—InternetArchiveBot (Report bug) 07:33, 20 September 2017 (UTC)
thread_title:  External links modified 

message: Currently at the top of this article are two template messages:
1) "This article relies too much on references to primary sources. (August 2018)"
2) "This article contains content that is written like an advertisement. (August 2018)"
I have no connection to this company. But I have to say, after reading this page, it seems that these claims are false. First, the article relies on dozens of secondary news stories, which are not primary sources. Second, the article - which I re-read in full - is written in a very matter-of-fact, neutral way. It does not promote the company. There is no marketing-type language. So this claim does not make sense.
I hope someone can address why these template messages are there. Thanks. --Sean06889 (talk) 15:18, 25 October 2018 (UTC)
replies: text: I agree. Being that there has been no discussion or opposition to this, I will be deleting template messages. --Biodefenseguy (talk) 19:08, 30 October 2018 (UTC)
replies: text: Not false. Too many primary sources and all "rah rah" stuff; not a thing that is interesting from a biotech business perspective. Wikipedia is not the company's website or a place to flog stocks. Jytdog (talk) 19:58, 30 October 2018 (UTC)
thread_title:  Template messages are false 

message: The second sentence is ungrammatical:
"Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, opioid overdoses, and provides medical devices for biodefense purposes." 128.120.251.7 (talk) 19:13, 6 April 2021 (UTC)
thread_title:  Ungrammatical 

message: I have added an  tag to this article because of extensive editing by a UPE sockfarm, please see Wikipedia:Sockpuppet investigations/Frost joyce for evidence. The article will need a thorough review ensuring due weight, neutral language, and use of reliable sources before the tag is removed. MarioGom (talk) 14:10, 14 November 2021 (UTC)
thread_title:  Undisclosed paid edits